EurekAlert! -
28 Aug 2017 06:00
(D'Or Institute for Research and Education) In a recent study published in the scientific journal Translational Oncology, a group of Brazilian researchers tested the therapeutic effect of a combination of conventional -- common anti-cancer agents -- and new drugs -- under clinical trials. 'The results were very exciting because the successful outcome depended on the chemotherapy regimens. On the other hand, 'wrong' combination of drugs could elicit harmful effects.'
Share this Article